drugset / Trial / NCT06402136

Evaluation Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of 83-0060 in Healthy Volunteers

NCT06402136 ↗

RandomizedSequentialDouble-blindTreatment

Summary

This is a clinical study aiming to assess pharmacokinetics, pharmacodynamics and preliminary efficacy of 83-0060 in Healthy Volunteers

Timeline

Start
2024-04-15
Primary completion
2024-08-09
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject 83-0060 Unknown — Oral

Indications

No indication recorded.